Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Trump Shooting Recalls Memories Of Reagan Assassination Attempt: Here's How Markets React To Political Violence
Via Benzinga
Topics Government Product Recall
Exposures Legal Political Product Safety
Tickers DIA DJT SPY
CCHR Commends Congressional Action to Prevent Continued Use of Electrical Shocking Device
Via Press Release Distribution Service
Exposures Product Safety
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
Via The Motley Fool
Exposures Product Safety
Tickers LLY
Bill Gates Recalls Barack Obama's Mission To Capture Osama bin Laden In Pakistan Using Fake Polio Vaccination Campaign: '...A Lot Of Damage Had Been Done'
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers MSFT
Bipartisan Effort At U.S. Capitol Calls On FDA To Approve MDMA Therapy For Vets And Others With PTSD
Via Benzinga
Exposures Product Safety
First Choice Neurology Pioneering Neurologists Administer the New FDA-Approved Drug Kisunla
Via PRLog
Exposures Product Safety
Tickers LLY
Silk Recalls 2024: What to Know as Plant-Based Milk Recalled Over Listeria Concerns
Via InvestorPlace
Topics Product Recall
Exposures Legal Product Safety
Tickers FCEL JOBY KZIA WMT
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Prepares to Submit Briefing Book to FDA, Looks to Obtain Key Feedback Regarding NDA for CNM-Au8 in ALS
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Salmonella Saga: FDA Reportedly Uncovers Years of Contamination at PepsiCo Plant
Via Benzinga
Exposures Product Safety
Tickers CHWY IYK PEP XLP
From Chicago Streets to California Politics: A Riveting Memoir of Triumph Over Adversity
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Surprise Buying Opportunity on This Dividend Aristocrat
Via MarketBeat
Topics Economy Product Recall
Exposures Interest Rates Legal Product Safety
Tickers PEP
FDA Rejects Novo Nordisk's Weekly Insulin, Requests Information Related To Manufacturing Process, Type 1 Diabetes
Via Benzinga
Exposures Product Safety
Tickers NVO
Windsor Park: Decades of Sinking Homes and the Path to New Beginnings
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
Citius Pharmaceuticals (CTXR) Nears Key FDA Decisions and Launch Plans for 2024
Via AB Newswire
Exposures Product Safety
Tickers CTXR
TechMediaBreaks – Longeveron Inc.’s (NASDAQ: LGVN) Lomecel-B(TM) Granted RMAT Designation for the Treatment of Mild Alzheimer’s Disease
Via Investor Brand Network
Exposures Product Safety
Tickers LGVN
Kazia Therapeutics Shares Are Jumping Today: Successful Study For Brain Cancer Treatment
Via Benzinga
Exposures Product Safety
Tickers KZIA
FDA Approves Expanded Use Of Arcutis Biotherapeutics' Eczema Drug For Patients As Young As 6 Years
Via Benzinga
Exposures Product Safety
Tickers ARQT
Why Is Longeveron Stock Soaring On Wednesday?
Via Benzinga
Exposures Product Safety
Tickers LGVN
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Elected New Board Member at Annual Stockholder Meeting
Via Investor Brand Network
Exposures Product Safety
Tickers LGVN
Stellantis Recalls More Than 341K Vehicles Over Concerns Of Airbag Non-Deployment, Incorrect Pressure Information On Tire Placard
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers STLA
Cybin Inc. Stands Strong As A Remaining Force To Prove Benefits Of Psychedelic Therapeutics ($CYBN)
Via AB Newswire
Exposures Product Safety
Tickers CYBN
FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base
Via Benzinga
Exposures Product Safety
Tickers XOMA ZVRA
FDA Labels Inspire Medical's Sleep Apnea Nerve Stimulator Recall As Most Serious
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers INSP
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Second GLP-1 Human Pilot Study
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers LEXX
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Second GLP-1 Human Pilot Study
Via CannabisNewsWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers LEXX
EV Manufacturers Lucid Motors And Fisker Launch Recalls On Thousands Of EVs - Read Why
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers LCID
Fisker Stock: Bankrupt EV Maker Recalls 11,000 SUVs
Via InvestorPlace
Topics Bankruptcy Product Recall
Exposures Financial Legal Product Safety
Tickers FSRNQ
Zepbound Savings Prescription Card For Walgreens, CVS, Kroger, Walmart Launched
Via Press Release Distribution Service
Exposures Product Safety
Tickers KR WBA WMT
Brinton Vision Releases Article Discussing Question: Is LASIK Safe
Via Press Advantage
Exposures Product Safety
LCID Stock Alert: Lucid Motors Issues 2 New Recalls
Via InvestorPlace
Topics Electric Vehicles Product Recall
Exposures Electric Vehicles Legal Product Safety
Tickers LCID
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.